The biopharmaceutical contract manufacturing sector is anticipated to grow significantly, reaching an estimated US$ 27,868.50 million by 2028, up from US$ 15,735.04 million in 2021. This growth represents a compound annual growth rate (CAGR) of 8.5% from 2021 to 2028. A major driver of this expansion is the increasing trend of outsourcing among pharmaceutical companies. Historically, the contract manufacturing industry was considered a specialized service market, providing additional manufacturing capacity or specific services to pharmaceutical firms. The emergence of Contract Manufacturing Organizations (CMOs) has been largely influenced by the rising incidence of drug manufacturing failures.
In the past, pharmaceutical companies typically managed their own manufacturing facilities to produce innovative drugs. However, to mitigate the risks associated with overcapacity, there has been a consistent rise in the demand for outsourced manufacturing solutions. Recently, Revolo Biotherapeutics formed a partnership with the contract development and manufacturing organization Northway Biotech to produce Revolo's binding immuno-regulatory protein 1805. This collaboration encompasses a range of services, including cell line development and protein manufacturing, along with quality assurance and regulatory compliance support.
Similarly, Gland Pharma has been engaged in the production of Remdesivir for multiple companies, including Mylan, since 2021, and has increased its manufacturing capacity in response to heightened demand. In another instance, Samsung Biologics and GI Innovation entered into a contract in 2019 for immunochemotherapy, where Samsung Biologics provided services from cell line development to the production of Phase-I drug substances. The growing number of agreements between biopharmaceutical firms and contract manufacturers indicates a robust expansion of the biopharmaceutical contract manufacturing market.
The global biopharmaceutical contract manufacturing market can be categorized based on product type, service offerings, and source of biologics. In terms of product segmentation, the market is divided into biologics and biosimilars. The biologics segment is projected to capture the largest market share from 2021 to 2028. This segment is expected to experience substantial growth due to the diverse range of products it encompasses, including monoclonal antibodies, recombinant proteins, vaccines, and more. The demand for biologics is on the rise, driven by increased research and development activities aimed at creating new drug products for chronic conditions. Additionally, the COVID-19 pandemic has further propelled the growth of the biologics segment, particularly with the heightened need for vaccines and monoclonal antibodies to address various chronic diseases stemming from metabolic, infectious, neurological, and other origins.
When examining the services offered, the biopharmaceutical contract manufacturing market is divided into several categories: process development, fill and finish operations, analytical and quality control studies, and packaging. The process development segment is expected to dominate the market during the forecast period, as it attracts the highest investments necessary for the production of any biopharmaceutical. The emphasis on scaling up from pilot to commercial production, along with cell line development and other related processes, is likely to create significant growth opportunities within this segment. Furthermore, the process development segment is subdivided into downstream and upstream processing, with downstream processing anticipated to hold a larger market share due to the greater volume of products developed in this area. The analytical and quality control studies segment is also expected to witness the highest growth rate.
In terms of sources, the biopharmaceutical contract manufacturing market is categorized into mammalian and microbial-based biologics/non-mammalian sources. The mammalian segment is projected to maintain a larger market share, as mammalian cell sources are more prevalent in the industry and can produce a wider array of products compared to microbial or non-mammalian sources.
Key organizations such as the World Health Organization (WHO), Association of Clinical Research Organizations (ACRO), European Federation of Pharmaceuticals Industries Associations (EFPIA), and Pharmaceutical Research and Manufacturers of America (PhRMA) are among the primary and secondary sources referenced in the analysis of the biopharmaceutical contract manufacturing market.
TABLE OF CONTENTS
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Analyst Market Outlook
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
 3.2.1 Hypothesis formulation:
 3.2.2 Macro-economic factor analysis:
 3.2.3 Developing base number:
 3.2.4 Data Triangulation:
 3.2.5 Country level data:
3.3 Assumptions and Limitations
4. Biopharmaceutical Contract Manufacturing Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Biopharmaceutical Contract Manufacturing Market - Key Market Dynamics
5.1 Biopharmaceutical Contract Manufacturing Market - Key Market Dynamics
5.2 Market Drivers:
 5.2.1 Rising Demand for Biologics
 5.2.2 Increasing Demand for Cost Efficiency and Flexibility
5.3 Market Restraints
 5.3.1 Tightened Budget and Economic Uncertainty
5.4 Market Opportunities
 5.4.1 Increasing Demand for Personalized Medicine
5.5 Future Trends
 5.5.1 Advanced Manufacturing Technologies
5.6 Impact of Drivers and Restraints:
6. Biopharmaceutical Contract Manufacturing Market - Global Market Analysis
6.1 Biopharmaceutical Contract Manufacturing Market Revenue (US$ Million), 2021-2031
6.2 Biopharmaceutical Contract Manufacturing Market Forecast Analysis
7. Biopharmaceutical Contract Manufacturing Market Analysis - by Product Type
7.1 Biologics
 7.1.1 Overview
 7.1.2 Biologics: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Biosimilar
 7.2.1 Overview
 7.2.2 Biosimilar: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
8. Biopharmaceutical Contract Manufacturing Market Analysis - by Source
8.1 Microbial
 8.1.1 Overview
 8.1.2 Microbial: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Mammalian
 8.2.1 Overview
 8.2.2 Mammalian: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
9. Biopharmaceutical Contract Manufacturing Market Analysis - by Application
9.1 Commercial
 9.1.1 Overview
 9.1.2 Commercial: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Clinical
 9.2.1 Overview
 9.2.2 Clinical: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
10. Biopharmaceutical Contract Manufacturing Market Analysis - by Therapeutic Area
10.1 Oncology
 10.1.1 Overview
 10.1.2 Oncology: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
10.2 Autoimmune Disorders
 10.2.1 Overview
 10.2.2 Autoimmune Disorders: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Respiratory Disorders
 10.3.1 Overview
 10.3.2 Respiratory Disorders: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
10.4 Metabolic Disorders
 10.4.1 Overview
 10.4.2 Metabolic Disorders: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
10.5 Neurology
 10.5.1 Overview
 10.5.2 Neurology: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
10.6 Infectious Diseases
 10.6.1 Overview
 10.6.2 Infectious Diseases: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
10.7 Others
 10.7.1 Overview
 10.7.2 Others: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
11. Biopharmaceutical Contract Manufacturing Market - Geographical Analysis
11.1 North America
 11.1.1 North America Biopharmaceutical Contract Manufacturing Market Overview
 11.1.2 North America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2031 (US$ Million)
 11.1.2.1 North America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Product Type
 11.1.2.2 North America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Source
 11.1.2.3 North America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Application
 11.1.2.4 North America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Therapeutic Area
 11.1.3 North America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Country
 11.1.3.1 United States: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
 11.1.3.1.1 United States: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
 11.1.3.1.2 United States: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
 11.1.3.1.3 United States: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
 11.1.3.1.4 United States: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
 11.1.3.2 Canada: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
 11.1.3.2.1 Canada: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
 11.1.3.2.2 Canada: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
 11.1.3.2.3 Canada: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
 11.1.3.2.4 Canada: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
 11.1.3.3 Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
 11.1.3.3.1 Mexico: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
 11.1.3.3.2 Mexico: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
 11.1.3.3.3 Mexico: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
 11.1.3.3.4 Mexico: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
11.2 Europe
 11.2.1 Europe Biopharmaceutical Contract Manufacturing Market Overview
 11.2.2 Europe: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2031 (US$ Million)
 11.2.2.1 Europe: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Product Type
 11.2.2.2 Europe: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Source
 11.2.2.3 Europe: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Application
 11.2.2.4 Europe: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Therapeutic Area
 11.2.3 Europe: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Country
 11.2.3.1 Germany: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
 11.2.3.1.1 Germany: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
 11.2.3.1.2 Germany: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
 11.2.3.1.3 Germany: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
 11.2.3.1.4 Germany: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
 11.2.3.2 United Kingdom: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
 11.2.3.2.1 United Kingdom: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
 11.2.3.2.2 United Kingdom: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
 11.2.3.2.3 United Kingdom: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
 11.2.3.2.4 United Kingdom: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
 11.2.3.3 France: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
 11.2.3.3.1 France: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
 11.2.3.3.2 France: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
 11.2.3.3.3 France: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
 11.2.3.3.4 France: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
 11.2.3.4 Italy: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
 11.2.3.4.1 Italy: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
 11.2.3.4.2 Italy: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
 11.2.3.4.3 Italy: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
 11.2.3.4.4 Italy: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
 11.2.3.5 Spain: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
 11.2.3.5.1 Spain: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
 11.2.3.5.2 Spain: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
 11.2.3.5.3 Spain: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
 11.2.3.5.4 Spain: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
 11.2.3.6 Rest of Europe: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
 11.2.3.6.1 Rest of Europe: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
 11.2.3.6.2 Rest of Europe: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
 11.2.3.6.3 Rest of Europe: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
 11.2.3.6.4 Rest of Europe: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
11.3 Asia Pacific
 11.3.1 Asia Pacific Biopharmaceutical Contract Manufacturing Market Overview
 11.3.2 Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2031 (US$ Million)
 11.3.2.1 Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Product Type
 11.3.2.2 Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Source
 11.3.2.3 Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Application
 11.3.2.4 Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Therapeutic Area
 11.3.3 Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Country
 11.3.3.1 China: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
 11.3.3.1.1 China: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
 11.3.3.1.2 China: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
 11.3.3.1.3 China: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
 11.3.3.1.4 China: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
 11.3.3.2 Japan: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
 11.3.3.2.1 Japan: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
 11.3.3.2.2 Japan: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
 11.3.3.2.3 Japan: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
 11.3.3.2.4 Japan: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
 11.3.3.3 India: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
 11.3.3.3.1 India: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
 11.3.3.3.2 India: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
 11.3.3.3.3 India: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
 11.3.3.3.4 India: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
 11.3.3.4 Australia: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
 11.3.3.4.1 Australia: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
 11.3.3.4.2 Australia: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
 11.3.3.4.3 Australia: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
 11.3.3.4.4 Australia: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
 11.3.3.5 South Korea: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
 11.3.3.5.1 South Korea: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
 11.3.3.5.2 South Korea: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
 11.3.3.5.3 South Korea: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
 11.3.3.5.4 South Korea: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
 11.3.3.6 Rest of APAC: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
 11.3.3.6.1 Rest of APAC: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
 11.3.3.6.2 Rest of APAC: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
 11.3.3.6.3 Rest of APAC: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
 11.3.3.6.4 Rest of APAC: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
11.4 Middle East & Africa
 11.4.1 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Overview
 11.4.2 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2031 (US$ Million)
 11.4.2.1 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Product Type
 11.4.2.2 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Source
 11.4.2.3 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Application
 11.4.2.4 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Therapeutic Area
 11.4.3 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Country
 11.4.3.1 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
 11.4.3.1.1 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
 11.4.3.1.2 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
 11.4.3.1.3 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
 11.4.3.1.4 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
 11.4.3.2 South Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
 11.4.3.2.1 South Africa: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
 11.4.3.2.2 South Africa: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
 11.4.3.2.3 South Africa: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
 11.4.3.2.4 South Africa: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
 11.4.3.3 United Arab Emirates: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
 11.4.3.3.1 United Arab Emirates: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
 11.4.3.3.2 United Arab Emirates: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
 11.4.3.3.3 United Arab Emirates: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
 11.4.3.3.4 United Arab Emirates: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
 11.4.3.4 Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
 11.4.3.4.1 Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
 11.4.3.4.2 Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
 11.4.3.4.3 Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
 11.4.3.4.4 Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
11.5 South & Central America
 11.5.1 South & Central America Biopharmaceutical Contract Manufacturing Market Overview
 11.5.2 South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2031 (US$ Million)
 11.5.2.1 South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Product Type
 11.5.2.2 South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Source
 11.5.2.3 South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Application
 11.5.2.4 South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Therapeutic Area
 11.5.3 South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Country
 11.5.3.1 Brazil: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
 11.5.3.1.1 Brazil: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
 11.5.3.1.2 Brazil: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
 11.5.3.1.3 Brazil: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
 11.5.3.1.4 Brazil: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
 11.5.3.2 Argentina: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
 11.5.3.2.1 Argentina: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
 11.5.3.2.2 Argentina: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
 11.5.3.2.3 Argentina: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
 11.5.3.2.4 Argentina: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
 11.5.3.3 Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
 11.5.3.3.1 Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
 11.5.3.3.2 Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
 11.5.3.3.3 Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
 11.5.3.3.4 Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
12. Competitive Landscape
12.1 Heat Map Analysis by Key Players
12.2 Company Positioning & Concentration
13. Industry Landscape
13.1 Overview
13.2 Expansion
13.3 New Product Development
13.4 Merger and Acquisition
13.5 Partnerships
13.6 Other Business Strategies
14. Company Profiles
14.1 Boehringer Ingelheim International GmbH
 14.1.1 Key Facts
 14.1.2 Business Description
 14.1.3 Products and Services
 14.1.4 Financial Overview
 14.1.5 SWOT Analysis
 14.1.6 Key Developments
14.2 Lonza Group AG
 14.2.1 Key Facts
 14.2.2 Business Description
 14.2.3 Products and Services
 14.2.4 Financial Overview
 14.2.5 SWOT Analysis
 14.2.6 Key Developments
14.3 Samsung Biologics Co Ltd
 14.3.1 Key Facts
 14.3.2 Business Description
 14.3.3 Products and Services
 14.3.4 Financial Overview
 14.3.5 SWOT Analysis
 14.3.6 Key Developments
14.4 Merck KGaA
 14.4.1 Key Facts
 14.4.2 Business Description
 14.4.3 Products and Services
 14.4.4 Financial Overview
 14.4.5 SWOT Analysis
 14.4.6 Key Developments
14.5 AbbVie Inc
 14.5.1 Key Facts
 14.5.2 Business Description
 14.5.3 Products and Services
 14.5.4 Financial Overview
 14.5.5 SWOT Analysis
 14.5.6 Key Developments
14.6 WuXi Biologics Inc
 14.6.1 Key Facts
 14.6.2 Business Description
 14.6.3 Products and Services
 14.6.4 Financial Overview
 14.6.5 SWOT Analysis
 14.6.6 Key Developments
14.7 Ajinomoto Co Inc
 14.7.1 Key Facts
 14.7.2 Business Description
 14.7.3 Products and Services
 14.7.4 Financial Overview
 14.7.5 SWOT Analysis
 14.7.6 Key Developments
14.8 Cytiva
 14.8.1 Key Facts
 14.8.2 Business Description
 14.8.3 Products and Services
 14.8.4 Financial Overview
 14.8.5 SWOT Analysis
 14.8.6 Key Developments
14.9 AGC Biologics AS
 14.9.1 Key Facts
 14.9.2 Business Description
 14.9.3 Products and Services
 14.9.4 Financial Overview
 14.9.5 SWOT Analysis
 14.9.6 Key Developments
15. Appendix
15.1 About
15.2 Glossary of Terms
LIST OF TABLES
Table 1. Biopharmaceutical Contract Manufacturing Market Segmentation
Table 2. North America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 3. North America: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 4. North America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
Table 5. North America: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
Table 6. North America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 7. North America: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 8. North America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
Table 9. North America: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
Table 10. United States: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 11. United States: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 12. United States: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
Table 13. United States: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
Table 14. United States: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 15. United States: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 16. United States: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
Table 17. United States: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
Table 18. Canada: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 19. Canada: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 20. Canada: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
Table 21. Canada: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
Table 22. Canada: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 23. Canada: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 24. Canada: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
Table 25. Canada: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
Table 26. Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 27. Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 28. Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
Table 29. Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
Table 30. Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 31. Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 32. Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
Table 33. Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
Table 34. Europe: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 35. Europe: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 36. Europe: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
Table 37. Europe: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
Table 38. Europe: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 39. Europe: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 40. Europe: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
Table 41. Europe: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
Table 42. Germany: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 43. Germany: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 44. Germany: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
Table 45. Germany: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
Table 46. Germany: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 47. Germany: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 48. Germany: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
Table 49. Germany: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
Table 50. United Kingdom: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 51. United Kingdom: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 52. United Kingdom: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
Table 53. United Kingdom: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
Table 54. United Kingdom: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 55. United Kingdom: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 56. United Kingdom: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
Table 57. United Kingdom: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
Table 58. France: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 59. France: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 60. France: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
Table 61. France: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
Table 62. France: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 63. France: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 64. France: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
Table 65. France: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
Table 66. Italy: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 67. Italy: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 68. Italy: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
Table 69. Italy: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
Table 70. Italy: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 71. Italy: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 72. Italy: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
Table 73. Italy: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
Table 74. Spain: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 75. Spain: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 76. Spain: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
Table 77. Spain: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
Table 78. Spain: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 79. Spain: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 80. Spain: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
Table 81. Spain: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
Table 82. Rest of Europe: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 83. Rest of Europe: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 84. Rest of Europe: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
Table 85. Rest of Europe: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
Table 86. Rest of Europe: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 87. Rest of Europe: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 88. Rest of Europe: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
Table 89. Rest of Europe: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
Table 90. Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 91. Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 92. Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
Table 93. Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
Table 94. Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 95. Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 96. Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
Table 97. Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue
LIST OF FIGURES
The List of Companies - Biopharmaceutical Contract Manufacturing Market
- Boehringer Ingelheim International GmbH
- Thermo Fisher Scientific Inc
- Lonza Group AG
- Merck KGaA
- AbbVie Inc.
- General Electric Co
- Samsung Biologics Co Ltd
- WuXi Biologics Inc
- Inno Bio Ventures Sdn Bhd
- Ajinomoto Co Inc.